| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Departments of Dermatology*and Virology,University of Cologne, Cologne; and the Department of Cancer Research,Fachklinik Hornheide, University of Münster, Münster, Germany
In wound healing epidermal-dermal interactions are known to regulate keratinocyte proliferation and differentiation. To find out how fibroblasts respond to epithelial stimuli, we characterized fibroblasts in monolayer co-culture with keratinocytes. On co-culture numerous extracellular matrix- and smooth muscle cell-associated gene transcripts were up-regulated in fibroblasts, suggesting a differentiation into myofibroblasts. Increased 
-smooth muscle actin (-SMA) protein expression in co-cultured fibroblasts started at approximately day 4, was serum-independent, but required endogenous transforming growth factor (TGF)-ß. In co-cultures, TGF-ß neutralizing monoclonal antibody strongly reduced -SMA induction. Endogenous TGF-ß production and activation were increased at 24 and 48 hours, requiring, like -SMA induction, close keratinocyte-fibroblast proximity. As myofibroblast differentiation only started after 4 days, we analyzed the presence of endogenous inhibitors at early time points. Blocking keratinocyte-derived interleukin (IL)-1 using IL-1 receptor antagonist, -SMA expression in co-cultures was potentiated. Conversely, adding exogenous IL-1 completely suppressed endogenous -SMA induction. In co-cultured fibroblasts strong nuclear factor-
B binding activity was observed from 2 hours, decreasing at 2 and 4 days, suggesting an early, IL-1-mediated inhibition of TGF-ß signaling in co-cultured fibroblasts. This biphasic differentiation event is regulated by the balance of endogenous TGF-ß and IL-1 activity and is reminiscent of myofibroblast differentiation at early and later stages of wound healing.
This article has been cited by other articles:
 |
|
 |
|
  D. D. Luo, C. Fielding, A. Phillips, and D. Fraser Interleukin-1 beta regulates proximal tubular cell transforming growth factor beta-1 signalling Nephrol. Dial. Transplant., May 6, 2009; (2009) gfp208v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kane, M. Jones, J. J. Brosens, P. T. K. Saunders, R. W. Kelly, and H. O. D. Critchley Transforming Growth Factor-{beta}1 Attenuates Expression of Both the Progesterone Receptor and Dickkopf in Differentiated Human Endometrial Stromal Cells Mol. Endocrinol., March 1, 2008; 22(3): 716 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lu, L. Tian, Y. Han, M. Vogelbaum, and G. R. Stark Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways PNAS, March 13, 2007; 104(11): 4365 - 4370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ishida, T. Kondo, A. Kimura, K. Matsushima, and N. Mukaida Absence of IL-1 Receptor Antagonist Impaired Wound Healing along with Aberrant NF-{kappa}B Activation and a Reciprocal Suppression of TGF-beta Signal Pathway J. Immunol., May 1, 2006; 176(9): 5598 - 5606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Faler, R. A. Macsata, D. Plummer, L. Mishra, and A. N. Sidawy Transforming Growth Factor-{beta} and Wound Healing Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2006; 18(1): 55 - 62. [Abstract] [PDF]
|
|
|
|
 |
|
 N. S. Tan, L. Michalik, B. Desvergne, and W. Wahli Genetic- or Transforming Growth Factor-{beta}1-induced Changes in Epidermal Peroxisome Proliferator-activated Receptor {beta}/{delta} Expression Dictate Wound Repair Kinetics J. Biol. Chem., May 6, 2005; 280(18): 18163 - 18170. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
